Phase II trial of letermovir compared with valganciclovir in transplant recipients with human cytomegalovirus viraemia post-transplantation

Trial Profile

Phase II trial of letermovir compared with valganciclovir in transplant recipients with human cytomegalovirus viraemia post-transplantation

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2009

At a glance

  • Drugs Letermovir; Valganciclovir
  • Indications Cytomegalic inclusion disorders; Cytomegalovirus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Sep 2009 New trial record
    • 15 Sep 2009 Results presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 2009
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top